MYLAN 6869 MYLAN 6869 (Anagrelide 1 mg)
Pill imprint MYLAN 6869 MYLAN 6869 has been identified as Anagrelide hydrochloride 1 mg.
Anagrelide is used in the treatment of thrombocythemia; chronic myelogenous leukemia and belongs to the drug class miscellaneous uncategorized agents. Risk cannot be ruled out during pregnancy. Anagrelide 1 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- MYLAN 6869 MYLAN 6869
- Strength:
- 1 mg
- Color:
- Blue & Gray
- Size:
- 14.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous uncategorized agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-6869
- Inactive Ingredients:
- lactose anhydrous
crospovidone
magnesium stearate
microcrystalline cellulose
povidone
sodium lauryl sulfate
ferrosoferric oxide
gelatin
titanium dioxide
FD&C Blue No. 1
D&C Yellow No. 10
FD&C Blue No. 2
FD&C Red No. 40
propylene glycol
shellac
More about anagrelide
Consumer resources
- Other brands: Agrylin
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
